FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline.
D000316:Adrenergic alpha-Agonists; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002490:Central Nervous System / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006614:Hindlimb / Q000187:drug effects; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D012018:Reflex / Q000187:drug effects; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism; D014230:Triazoles / Q000494:pharmacology*; D015016:Yohimbine / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D008781:Methyltyrosines; D014230:Triazoles; D010643:Phenoxybenzamine; D015016:Yohimbine; C014891:FLA-136; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine